Brand-name vs compounded
Ro.co vs Maximus: Brand-Name or Compounded? (2026)
Ro.co or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Ro.co and Maximus side by side and the marketing reads almost identically. The programs underneath do not.
Choosing between them is really choosing between an approved finished drug and a compounded preparation. Ro.co sits on one side of that line and Maximus on the other, and no amount of feature comparison makes the distinction go away.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $133/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Quickest to start
- Ro.co — Online consultation, then home delivery.
- Easiest to pay for
- Ro.co — Neither publishes financing; both expect the full amount monthly.
The short version: Ro.co vs Maximus
The rows below are the ones that differ enough between these two to be worth your attention.
| Ro.co | Maximus | |
|---|---|---|
| Advertised price | Get started online for $39 | $132.99/mo |
| Rate after promotions | $39/mo | $133/mo |
| Pricing structure | Promotional first month, then standard rate | Flat rate at every dose |
| Medication | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables | Compounded semaglutide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Online consultation | Telemedicine intake, no clinic visits |
| State coverage | Not published | Not published |
| Patient reviews | 40,215 | 2,896 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
Cost over a full course of treatment
Comparing entry prices across these two would be actively misleading, because they escalate differently. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Ro.co | Maximus | |
|---|---|---|
| First month | $39 | $133 |
| Months 2 onward | Not published | $133/mo |
| 6-month total | Not computable | $798 |
| 12-month total | Not computable | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
The regulatory difference, in plain terms
Ro.co supplies FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
Across from that, Maximus offers compounded semaglutide — prepared by a pharmacy rather than manufactured under approval. The price advantage and the reduced oversight are the same fact seen from two sides.
Neither choice is wrong, but they are different risks. Paying $39/mo buys regulatory certainty. Paying less buys access, on terms where the manufacturing oversight is not the same.
Inside the Ro.co program
The pitch is the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
You start with online consultation; medication arrives via home delivery. The price behaves as promotional first month, then standard rate.
Established full-service platform with clinician oversight. The formulary covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- No hidden fees; pricing disclosed before you complete your consultation
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Get started online for just $39
- FDA-approved finished medication, not compounded
Ro.co cons
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Less price-competitive than compounded-only platforms for budget-driven patients
The reservation worth holding, particularly next to Maximus: an FDA-approved finished medication costs multiples of a compounded vial.
How Maximus works
$132.99 per Month
The process is telemedicine intake, no clinic visits, then home delivery. On money, expect flat rate at every dose — published upfront.
What continues after the first shipment: prescriptions approved by licensed doctors, filled through U.S. pharmacies. Formulary: compounded semaglutide.
Maximus pros
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
- Prescriptions approved by licensed doctors
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
Read next to Ro.co, the weak point: the smallest patient base here, with limited published detail on tirzepatide.
Ro.co or Maximus: matching the program to the patient
Choose Ro.co if:
- the level of clinical contact suits you: established full-service platform with clinician oversight
- you want to start on their timeline: online consultation
- delivery works the way you want it to: home delivery
- the monthly rate is the constraint — $39/mo against $133/mo
Choose Maximus if:
- you want the price you sign up at to survive titration
- you want the full price in front of you before completing an intake
- you would get real value from a low flat rate with a simple direct-pay structure and nothing bolted on
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
The compromises on both sides
On price. Ro.co is the cheaper program at $39/mo against $133/mo. What Ro.co gives up for that is an FDA-approved finished medication costs multiples of a compounded vial; what Maximus charges for is a low flat rate with a simple direct-pay structure and nothing bolted on.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. Ro.co provides established full-service platform with clinician oversight. Maximus provides prescriptions approved by licensed doctors, filled through U.S. pharmacies. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables; Maximus covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The medication, not the platform
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Ro.co vs Maximus: common questions
What happens when Ro.co's promotional price ends?
Ongoing medication pricing varies by plan and is set after the consultation. Ask for it before the first charge, since it governs almost the entire cost of a year of treatment.
Which is cheaper to start, Ro.co or Maximus?
Ro.co, at $39 against $133. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Does the price go up as my dose increases?
At Maximus, no — a low flat rate with a simple direct-pay structure and nothing bolted on. At Ro.co, the published structure is promotional first month, then standard rate. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Which has more patient reviews, Ro.co or Maximus?
Ro.co, with 40,215 against 2,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Ro.co compared with Maximus?
Ro.co advertises online consultation, with home delivery. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Ro.co or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both Ro.co and Maximus price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Maximus's case is a low flat rate with a simple direct-pay structure and nothing bolted on; its cost: the smallest patient base here, with limited published detail on tirzepatide.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Ro.co vs He & She MDBrand-name vs compounded
- Ro.co vs TMatesBrand-name vs compounded
- Enhance MD vs MaximusBudget vs premium
- Directmeds vs MaximusPublished price vs quote-only
- Hers vs TMatesBrand-name vs compounded
- Hers vs He & She MDBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Ro.co or Maximus, and does not sell treatment. Read our ranking methodology.